Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,600,365
+$529,161 QoQ
Shares Held
22,939
+4.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#303
of 849 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISSAY ASSET MANAGEMENT CORP /JAPAN holds $81,366,812 across 7 Biotechnology names. INCY ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,743 | $37,623,820 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,636 | $19,102,771 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,482 | $11,885,266 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
21,164 | $3,963,593 | |
| 5 | RPRX |
Royalty Pharma plc
|
56,729 | $3,180,795 | |
| 6 | INSM |
INSMED Inc
|
28,233 | $3,010,202 | |
| 7 | INCY |
Incyte Corp
This page
|
22,939 | $2,600,365 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,600,365 | 22,939 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,071,204 | 22,006 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,127,604 | 21,541 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,803,145 | 21,261 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,438,408 | 21,122 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,248,964 | 20,627 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,407,024 | 20,371 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,336,608 | 20,221 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,381,226 | 22,785 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,247,415 | 21,896 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,348,854 | 21,482 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,183,649 | 20,489 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,231,616 | 19,785 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,446,267 | 20,012 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,673,708 | 20,838 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,402,038 | 21,039 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,534,821 | 20,203 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,628,268 | 20,502 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,477,615 | 20,131 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,310,259 | 19,050 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,655,594 | 19,679 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,556,401 | 19,151 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $17,445,491 | 200,569 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $23,852,084 | 265,791 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $22,969,780 | 220,927 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $16,966,439 | 231,687 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||